| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/14/2010 | US7850981 Photodynamic treatment (PDT) to prevent/treat tumor metastatis by irradiation with a suboptimal dosage of light absorbed by a green porphyrin photosensitizer and an immunoadjuvant after which the photosensitizer mediates cell destruction without appreciable heating of the target tissue; anticarcinogenic |
| 12/14/2010 | US7850980 Chlamydia OMP antigen |
| 12/14/2010 | US7850976 Insulin resistance improving agents |
| 12/14/2010 | US7850973 Amino acid composition comprising a multivalent branched multiple antigen peptide (MAP) linked to a carrier for induction of immune response to amyloid beta deposition in brain; treatment and prevention of nervous system disorders |
| 12/14/2010 | US7850971 PSMA antibodies and protein multimers |
| 12/14/2010 | US7850970 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax |
| 12/14/2010 | US7850969 Apparatus for reducing secretory activity of leukocytes which comprises plastic housing, carriers, blood inlet/outlet nozzles and an antibody against Fas (CD95) that is linked to the carrier |
| 12/14/2010 | US7850963 Vascular endothelial growth factor 2 |
| 12/14/2010 | US7850962 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease |
| 12/14/2010 | CA2462376C Liposome loading with metal ions |
| 12/14/2010 | CA2461890C Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
| 12/14/2010 | CA2458524C C2-disubstituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 12/14/2010 | CA2446673C Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 12/14/2010 | CA2433858C Purine derivatives as purinergic receptor antagonists |
| 12/14/2010 | CA2420292C Contraception process and administration form for the same |
| 12/14/2010 | CA2267893C Method and potentiated composition for treating migraine |
| 12/09/2010 | WO2010141427A1 Treatment of ophthalmologic disorders mediated by albha-carbonic anhydrase isoforms |
| 12/09/2010 | WO2010140694A1 Method for screening of inhibitor using factor capable of enhancing production of amyloid-beta peptide, and inhibitor obtained by same |
| 12/09/2010 | WO2010140531A1 Pharmaceutical composition, food or beverage, and methods for these products |
| 12/09/2010 | WO2010139985A1 The use of amlexanox in the therapy of neutrophil-driven diseases |
| 12/09/2010 | WO2010139805A1 Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections |
| 12/09/2010 | WO2010139678A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms |
| 12/09/2010 | WO2010139627A1 New compositions for treating cmt and related disorders |
| 12/09/2010 | WO2010139064A1 Method of treating staphylococcal infection |
| 12/09/2010 | WO2010100060A3 Method for increasing endogenous plasmalogen levels in mammals |
| 12/09/2010 | WO2010020789A3 Medicament combination comprising alkaloids and a purine analog antiviral agent |
| 12/09/2010 | US20100312525 Ribosome Structure and Protein Synthesis Inhibitors |
| 12/09/2010 | US20100311785 Combination Therapy For Modulating The Human Sexual Response |
| 12/09/2010 | US20100311705 Ophthalmologic irrigation solutions and method |
| 12/09/2010 | US20100311665 Method and Composition for Potentiating an Opiate Analgesic |
| 12/09/2010 | US20100311662 Treatment of Acute Coronary Syndrome with an Exendin |
| 12/09/2010 | US20100311075 Human sodium-dependent bile acid transporter proteins |
| 12/09/2010 | US20100311045 Cancer |
| 12/09/2010 | US20100310627 Xenotransplant for Stroke Therapy |
| 12/09/2010 | US20100310506 Immunoconjugates for the Treatment of Tumours |
| 12/09/2010 | CA2764517A1 Dosage form |
| 12/09/2010 | CA2763495A1 New compositions for treating cmt and related disorders |
| 12/08/2010 | EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof |
| 12/08/2010 | EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 12/08/2010 | EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides |
| 12/08/2010 | EP2258447A2 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy |
| 12/08/2010 | EP2258396A1 Transdermally absorbable preparation |
| 12/08/2010 | EP2258394A1 Oral dosage form comprising a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 12/08/2010 | EP2258393A1 Abc transporter protein expression inhibitor |
| 12/08/2010 | EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer |
| 12/08/2010 | EP2258371A1 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 12/08/2010 | EP2258364A1 Preventive and/or remedy for vascular diseases |
| 12/08/2010 | EP2258363A1 Compositions for treatment of cancers |
| 12/08/2010 | EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 12/08/2010 | EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/08/2010 | EP2258347A2 Tamper-resistant products for opioid delivery |
| 12/08/2010 | EP2258341A2 Gastric acid secretion inhibiting composition |
| 12/08/2010 | EP2258183A1 Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs |
| 12/08/2010 | EP2257310A2 Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents |
| 12/08/2010 | EP2257294A2 Treatment of herpes virus related diseases |
| 12/08/2010 | EP2257293A2 Combination therapy with c-met and egfr antagonists |
| 12/08/2010 | EP2257290A1 Kit, composition, product or medicament for treating cognitive impairment |
| 12/08/2010 | EP2257285A1 Combination anti-cancer agents |
| 12/08/2010 | EP2257281A2 Combination comprising a cannabinoid receptor binding compound and an opioid |
| 12/08/2010 | EP2257172A2 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| 12/08/2010 | EP1857108B1 Preventive or therapeutic agent for herpesvirus-related disease |
| 12/08/2010 | EP1578409B1 Use of adenosine a2a receptor antagonists for treatment or prevention of extra-pyramidal syndrome |
| 12/08/2010 | EP1578351B1 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 12/08/2010 | EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents |
| 12/08/2010 | EP1480674B1 Treatment of central nervous system damage |
| 12/08/2010 | EP1395284B1 Non-depleting anti-CD4 antibody TRX1 and its uses |
| 12/08/2010 | EP1322318B1 Use of probiotic lactic acid bacteria for preventing ultraviolet radiation induced inflammatory or allergic reaction or immunosuppression in the skin |
| 12/08/2010 | EP1007017B2 Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof |
| 12/08/2010 | EP0826041B1 Transforming growth factor alpha hii |
| 12/08/2010 | CN1946411B Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination |
| 12/08/2010 | CN1850271B Medicinal composition for treating neurasthenia or somatic form disorders |
| 12/08/2010 | CN1803837B Neurotrophic growth factor |
| 12/08/2010 | CN1756527B Regulation of mammalian hair growth |
| 12/08/2010 | CN1620453B Thiazolidinedione derivative and its use as antidiabetic |
| 12/08/2010 | CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 12/08/2010 | CN101910182A Antitumor agent |
| 12/08/2010 | CN101909693A Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases |
| 12/08/2010 | CN101909650A Use of an acetylsalicylic acid salt for the treatment of viral infections |
| 12/08/2010 | CN101909649A Compositions and methods for treating asthma and lung disorders |
| 12/08/2010 | CN101909636A Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates |
| 12/08/2010 | CN101909609A Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 12/08/2010 | CN101909604A Method of treating dysglycemia and glucose excursions |
| 12/08/2010 | CN101909586A External skin preparation for pimpled skin |
| 12/08/2010 | CN101905024A Composition comprising and method of using angiopoietin-like protein 3 ANGPTl3 |
| 12/08/2010 | CN101905023A Method of effectively using medicine and method concerning prevention of side effect |
| 12/08/2010 | CN101560718B Method for preparing functional nano fibrous membrane by multi-component consolute single-step method |
| 12/08/2010 | CN101380317B Pharmaceutical composition for easing pruritus |
| 12/08/2010 | CN101185652B Remedies for lung cancer |
| 12/08/2010 | CN100998575B Finger nail coating agent of antifungal agent and its preparing method |
| 12/07/2010 | USRE41990 epothilone derivatives used for the treatment of cancer and cancers which have developed a multidrug-resistant phenotype; anticarcinogenic agents |
| 12/07/2010 | US7846957 Aromatase inhibition to enhance assisted reproduction |
| 12/07/2010 | US7846936 Antagonists of receptors of enothelial growth factor, platelet-derived growth factor, fibroblast growth factor, epidermal growth factors, HER2, IGF1R, HGFR or c-Kit, which is further an antagonist of a src tyrosine kinase family member, and chemotherapeutic agent; co-treatment with radiation therapy |
| 12/07/2010 | US7846919 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 12/07/2010 | US7846916 Steroid on carrier containing pressure sensitive adhesive |
| 12/07/2010 | US7846913 Include insomnia, erectile dysfunction, female sexual dysfunction, neuropathic pain, attention deficit disorder, and depression; NMDA receptor agonists as a learning-enhancing secondary drug that improves the efficacy of a primary drug by locking in the psychological benefits derived from primary drugs |
| 12/07/2010 | US7846911 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 12/07/2010 | US7846667 Using myeloblastosis oncogene expression profile as tool in detection of cell proliferative disorders associated with respiratory system |
| 12/07/2010 | US7846479 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface |
| 12/07/2010 | US7846468 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/07/2010 | US7846441 Treatment with anti-ErbB2 antibodies |